Literature DB >> 30136202

The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.

Salem Y Mohamed1, Randa Mohamed Kaf2, Mona Mostafa Ahmed2, Amira Elwan3, Hassan R Ashour4, Amr Ibrahim4.   

Abstract

BACKGROUND: Cancer stem cells proved to have a vital role in cell migration, invasion, metastasis, and treatment resistance of colorectal cancer (CRC) that subsequently lead to poor clinical outcomes. These stem cells may be a novel therapeutic target for the management of CRC progression. Signals of the Notch-1 pathway are responsible for acquisition of stem cell characters. ALDH1 and CD44 are usually detected in stem cells in colorectal cancer. AIM: The aims of this work are to evaluate the immunohistochemical expression of cancer stem cell markers ALDH1, Notch1, and CD44 in colorectal cancer and investigate their correlation with clinicopathological characters and patient survival.
METHODS: Paraffin-embedded specimens of 70 patients with primary colorectal carcinoma were analyzed for Notch 1, ALDH1, and CD44 expressions by immunohistochemistry.
RESULTS: Notch1 was mainly located in the cytoplasm of CRC tissues, rarely expressed in adjacent normal tissues. A highly statistically significant relationship was found between grading, lymphovascular invasion, the degree of lymphocytic infiltration, peritumoral budding, lymph node ratio, lymph node metastasis, and Notch1 expression (p < 0.001). There was a highly statistically significant relationship found between AJCC stage and Notch1 expression (p < 0.001). CD44 was mainly located in the cell membrane of CRC tissues. A highly statistically significant relationship was found between grading (p = 0.006), lymphovascular invasion, the degree of lymphocytic infiltration, peritumoral budding, lymph node metastasis, lymph node ratio, and CD44 expression (p < 0.001). There was a highly statistically significant relationship found between AJCC stage and CD44 expression (p < 0.001). ALDH1 was detected in the cytoplasm of the CRC tissue. A highly statistically significant relationship was found between grading, lymphovascular invasion, the degree of lymphocytic infiltration, peritumoral budding, lymph node metastasis, lymph node ratio, and ALDH1 expression (p < 0.001). There was a highly statistically significant relationship found between AJCC stage and ALDH1 expression (p < 0.001). There is a highly statistically significant direct correlation between Notch1, CD44 expression, and ALDH1 expression (p < 0.001).
CONCLUSIONS: There is a substantial correlation between Notch 1, ALDH1, and CD44 as cancer stem cell markers and lymph node metastasis, advanced stage and tumor recurrence in colorectal carcinoma.
CONCLUSION: Expression of stem cell markers ALDH1, Notch1, and CD44 correlates with poor prognosis in a CRC and represents an independent prognostic factor. They are associated with a feature of epithelial-mesenchymal transition evidenced by their association with high tumor burden.

Entities:  

Keywords:  ALDH1; CD44; CSCs; Notch1; Primary colorectal carcinoma

Mesh:

Substances:

Year:  2019        PMID: 30136202     DOI: 10.1007/s12029-018-0156-6

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  33 in total

1.  Loss of expression of the cancer stem cell marker aldehyde dehydrogenase 1 correlates with advanced-stage colorectal cancer.

Authors:  Crystal J Hessman; Emily J Bubbers; Kevin G Billingsley; Daniel O Herzig; Melissa H Wong
Journal:  Am J Surg       Date:  2012-03-09       Impact factor: 2.565

2.  A novel classification of tumour budding in colorectal cancer based on the presence of cytoplasmic pseudo-fragments around budding foci.

Authors:  E Shinto; H Mochizuki; H Ueno; O Matsubara; J R Jass
Journal:  Histopathology       Date:  2005-07       Impact factor: 5.087

3.  Notch1 and Notch2 have opposite prognostic effects on patients with colorectal cancer.

Authors:  D Chu; Z Zhang; Y Zhou; W Wang; Y Li; H Zhang; G Dong; Q Zhao; G Ji
Journal:  Ann Oncol       Date:  2011-03-04       Impact factor: 32.976

4.  Notch1 regulates the growth of human colon cancers.

Authors:  Yan Zhang; Bin Li; Zong-Zheng Ji; Peng-Sheng Zheng
Journal:  Cancer       Date:  2010-11-15       Impact factor: 6.860

5.  Combined preoperative CEA and CD44v6 improves prognostic value in patients with stage I and stage II colorectal cancer.

Authors:  L Chen; B Jiang; Z Wang; M Liu; H Yang; J Xing; C Zhang; Z Yao; N Zhang; M Cui; X Su
Journal:  Clin Transl Oncol       Date:  2013-07-17       Impact factor: 3.405

Review 6.  The Notch pathway in colorectal cancer.

Authors:  Kaitlyn E Vinson; Dennis C George; Alexander W Fender; Fred E Bertrand; George Sigounas
Journal:  Int J Cancer       Date:  2015-08-27       Impact factor: 7.396

7.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

Review 8.  The role of CD44 in epithelial-mesenchymal transition and cancer development.

Authors:  Hanxiao Xu; Yijun Tian; Xun Yuan; Hua Wu; Qian Liu; Richard G Pestell; Kongming Wu
Journal:  Onco Targets Ther       Date:  2015-12-16       Impact factor: 4.147

9.  Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis.

Authors:  Injae Hong; Seong Woo Hong; Yeo Goo Chang; Woo Yong Lee; Byungmo Lee; Yun Kyung Kang; You Sun Kim; In Wook Paik; Hyucksang Lee
Journal:  Ann Coloproctol       Date:  2015-06-30

10.  Expression and clinical significance of colorectal cancer stem cell marker EpCAMhigh/CD44+ in colorectal cancer.

Authors:  Dan Liu; Jinghua Sun; Jinming Zhu; Huan Zhou; Xian Zhang; Yang Zhang
Journal:  Oncol Lett       Date:  2014-02-21       Impact factor: 2.967

View more
  8 in total

1.  Immunohistochemical Analysis of Cancer Stem Cell Marker Expression in Papillary Thyroid Cancer.

Authors:  Hye Min Kim; Ja Seung Koo
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-02       Impact factor: 5.555

Review 2.  Mechanisms of Metastasis in Colorectal Cancer and Metastatic Organotropism: Hematogenous versus Peritoneal Spread.

Authors:  E Pretzsch; F Bösch; J Neumann; P Ganschow; A Bazhin; M Guba; J Werner; M Angele
Journal:  J Oncol       Date:  2019-09-19       Impact factor: 4.375

Review 3.  CD44 as a tumor biomarker and therapeutic target.

Authors:  Hanxiao Xu; Mengke Niu; Xun Yuan; Kongming Wu; Aiguo Liu
Journal:  Exp Hematol Oncol       Date:  2020-12-10

4.  Molecular features and gene expression signature of metastatic colorectal cancer (Review).

Authors:  Martina Poturnajova; Tatiana Furielova; Sona Balintova; Silvia Schmidtova; Lucia Kucerova; Miroslava Matuskova
Journal:  Oncol Rep       Date:  2021-03-02       Impact factor: 3.906

5.  ALDH2 promotes uterine corpus endometrial carcinoma proliferation and construction of clinical survival prognostic model.

Authors:  Yun-Qian Cui; Yuan Xiang; Fei Meng; Chun-Hui Ji; Rui Xiao; Jia-Peng Li; Zhou-Tong Dai; Xing-Hua Liao
Journal:  Aging (Albany NY)       Date:  2021-10-20       Impact factor: 5.682

Review 6.  Stemness, Inflammation and Epithelial-Mesenchymal Transition in Colorectal Carcinoma: The Intricate Network.

Authors:  Inese Briede; Dainis Balodis; Janis Gardovskis; Ilze Strumfa
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

7.  Circular RNA circPPP6R3 upregulates CD44 to promote the progression of clear cell renal cell carcinoma via sponging miR-1238-3p.

Authors:  Zhiliang Chen; Zaosong Zheng; Yingwei Xie; Qiyu Zhong; Wentai Shangguan; Yishan Zhang; Dingjun Zhu; Wenlian Xie
Journal:  Cell Death Dis       Date:  2021-12-21       Impact factor: 8.469

Review 8.  CD44: A Multifunctional Mediator of Cancer Progression.

Authors:  Malak Hassn Mesrati; Saiful Effendi Syafruddin; M Aiman Mohtar; Amir Syahir
Journal:  Biomolecules       Date:  2021-12-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.